ARTA
EVOK

A.R.T. Advisors’s Evoke Pharma EVOK Stock Holding History

A.R.T. Advisors’s Portfolio EVOK Stock Details EVOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-257
Closed -$32K – 1442
2019
Q3 		$32K Buy
+257
New +$34.4K ﹤0.01% 1347
2019
Q2 		– Sell
-106
Closed -$23K – 1437
2019
Q1 		$23K Buy
+106
New +$36.2K ﹤0.01% 1249
2018
Q1 		– Sell
-86
Closed -$27K – 1572
2017
Q4 		$27K Buy
+86
New +$35.6K ﹤0.01% 1305
2017
Q3 		– Sell
-107
Closed -$39K – 1423
2017
Q2 		$39K Buy
107
+30
+39% +$11.5K ﹤0.01% 1321
2017
Q1 		$34K Buy
+77
New +$31.5K ﹤0.01% 1351
2016
Q1 		– Sell
-173
Closed -$82K – 1448
2015
Q4 		$82K Buy
+173
New +$88K ﹤0.01% 1348
2014
Q1 		– Sell
-78
Closed -$83K – 1389
2013
Q4 		$83K Buy
+78
New +$112K ﹤0.01% 1203

Other funds holding EVOK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
WA
Wambolt & Associates Littleton, Colorado $297M AUM 17.23% 1-Year Est. Return

A.R.T. Advisors's EVOK Position: Q4 2019 in Review

A.R.T. Advisors sold out of Evoke Pharma (EVOK) in Q4 2019, closing a stake of 257 shares — an estimated $32K sold.

A.R.T. Advisors first reported a position in EVOK in Q4 2013 and held it in 7 quarters. The position peaked at $83K in Q4 2013. 16 funds tracked by Wall St. Rank hold EVOK as of Q4 2019.

  • A.R.T. Advisors reported no remaining Evoke Pharma position as of Q4 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 257 Evoke Pharma shares in Q4 2019, an estimated $32K.
  • A.R.T. Advisors first reported a position in Evoke Pharma in Q4 2013 and held it in 7 quarters.
  • A.R.T. Advisors's Evoke Pharma position peaked at $83K in Q4 2013.
  • 16 funds tracked by Wall St. Rank held Evoke Pharma as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.